Total Payments
$9,792
2024 Payments
$3,164
Companies
33
Transactions
567
Medicare Patients
1,460
Medicare Billing
$77,843
Payment Breakdown by Category
Food & Beverage$9,626 (98.3%)
Education$166.60 (1.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,626 | 564 | 98.3% |
| Education | $166.60 | 3 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,303 | 187 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $963.65 | 65 | $0 (2024) |
| Janssen Biotech, Inc. | $859.48 | 41 | $0 (2024) |
| Enterra Medical, Inc. | $526.41 | 8 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $464.11 | 56 | $0 (2024) |
| PFIZER INC. | $429.67 | 22 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $377.40 | 12 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $353.89 | 23 | $0 (2024) |
| Gilead Sciences, Inc. | $326.87 | 13 | $0 (2024) |
| Ardelyx, Inc. | $269.64 | 15 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,164 | 172 | ABBVIE INC. ($823.28) |
| 2023 | $2,490 | 117 | ABBVIE INC. ($802.61) |
| 2022 | $2,354 | 145 | ABBVIE INC. ($967.11) |
| 2021 | $1,784 | 133 | AbbVie Inc. ($710.15) |
All Payment Transactions
567 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $10.88 | General |
| Category: Gastroenterology | ||||||
| 12/19/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $34.01 | General |
| Category: THERAPY FOR CSID | ||||||
| 12/19/2024 | PFIZER INC. | VELSIPITY (Drug) | Food and Beverage | In-kind items and services | $1.85 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: Gastroenterology | ||||||
| 12/18/2024 | VIVUS LLC | QSYMIA (Drug) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $5.08 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $7.19 | General |
| Category: GI | ||||||
| 12/10/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $10.44 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $8.98 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/02/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: Gastroenterology | ||||||
| 11/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $8.22 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/21/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $8.56 | General |
| Category: GI | ||||||
| 11/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $94.78 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Janssen Scientific Affairs, LLC | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $46.05 | General |
| Category: Immunology | ||||||
| 11/20/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/20/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $5.39 | General |
| 11/19/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $25.36 | General |
| Category: LIVER DISEASE | ||||||
| 11/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $7.21 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/14/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $3.87 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $8.68 | General |
| Category: Gastroenterology | ||||||
| 11/13/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $7.23 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $30.60 | General |
| Category: Immunology | ||||||
| 11/11/2024 | Lilly USA, LLC | OMVOH (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 299 | 322 | $76,969 | $16,751 |
| 2022 | 5 | 465 | 535 | $129,939 | $27,502 |
| 2021 | 4 | 311 | 412 | $71,275 | $17,034 |
| 2020 | 4 | 385 | 451 | $85,226 | $16,556 |
Total Patients
1,460
Total Services
1,720
Medicare Billing
$77,843
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 61 | 71 | $10,508 | $2,361 | 22.5% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 51 | 51 | $10,952 | $1,814 | 16.6% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Facility | 2020 | 27 | 27 | $5,805 | $1,320 | 22.7% |
About Brandy Eason
Brandy Eason is a Family healthcare provider based in Little Rock, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/10/2016. The National Provider Identifier (NPI) number assigned to this provider is 1548629199.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Brandy Eason has received a total of $9,792 in payments from pharmaceutical and medical device companies, with $3,164 received in 2024. These payments were reported across 567 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($9,626).
As a Medicare-enrolled provider, Eason has provided services to 1,460 Medicare beneficiaries, totaling 1,720 services with total Medicare billing of $77,843. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Little Rock, AR
- Active Since 02/10/2016
- Last Updated 08/29/2023
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1548629199
Products in Payments
- RINVOQ (Biological) $1,198
- XIFAXAN (Drug) $936.80
- HUMIRA (Biological) $699.89
- STELARA (Biological) $691.97
- SKYRIZI (Biological) $575.61
- Linzess (Drug) $464.11
- DUPIXENT (Biological) $416.50
- ZENPEP (Drug) $396.96
- CREON (Drug) $319.22
- LINZESS (Drug) $314.46
- XELJANZ (Drug) $306.18
- IBSRELA (Drug) $269.64
- ENTYVIO (Biological) $256.28
- OCALIVA (Drug) $255.87
- VOQUEZNA (Drug) $239.84
- DIFICID (Drug) $214.51
- TREMFYA (Drug) $212.34
- VELSIPITY (Drug) $123.49
- Epclusa (Drug) $114.83
- SUCRAID (Drug) $108.75
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Little Rock
Anthony Echols
Family — Payments: $23,832
Family $23,832
Michael Stirling, Rn, Msn, C-Fnp, RN, MSN, C-FNP
Family — Payments: $20,967
Family $20,967
Lindsey Galloway
Family — Payments: $18,097
Family $18,097
Mrs. Emily Allen, Aprn, APRN
Family — Payments: $13,536
Family $13,536
Matthew Taylor, Aprn, Fnp-C, APRN, FNP-C
Family — Payments: $8,462
Family $8,462
Morgan Bittengle
Family — Payments: $7,683
Family $7,683